Pharmaxis conducts its own clinical trials as part of the regulatory approvals process for Aridol.
We also support independent trials of our products to provide further evidence of the efficacy and safety of our products. Studies are being conducted by leading clinicians around the world, including Australia, New Zealand, UK, US, Canada and Switzerland.
If you would like to participate in a clinical trial being run by Pharmaxis, or need further details about clinical trials’ progress please contact:
